Biotechs Seattle Genetics (SGEN) and Alkermes (ALKS) handily beat Wall Street’s fourth-quarter estimates Thursday, pushing Alkermes stock into a brief breakout as SGEN stock hit a five-month high. X Analysts were impressed by Seattle Genetics’ enthusiasm for its cancer treatment, Padcev. Guidance for full-year sales excluded the likelihood Padcev will …
Read More »
Chip design software maker Synopsys (SNPS) late Wednesday delivered better-than-expected earnings on in-line sales for its fiscal first quarter. But it guided lower than views for the current quarter. SNPS stock fell in extended trading. X The Mountain View, Calif.-based company earned an adjusted $2.62 a share on sales of …
Read More »
Chipmaker Analog Devices (ADI) on Wednesday crushed analyst estimates for its fiscal first quarter and with its guidance for the current period. ADI stock jumped in early trading. X The Wilmington, Mass.-based company earned an adjusted $2.75 a share on sales of $3.25 billion in the quarter ended Jan. 28. …
Read More »
Animal health giant Zoetis (ZTS) beat fourth-quarter sales expectations Tuesday and issued a strong 2023 outlook, leading ZTS stock to pop. X During the December period, sales rose 4% to $2.04 billion, narrowly topping forecasts for $2 billion, according to FactSet. Adjusted earnings jumped 15% to $1.15 per share and …
Read More »
Medical aesthetics company InMode (INMD) issued lighter-than-expected earnings guidance for 2023, sending INMD stock into the red early Tuesday. X For the year, InMode expects to earn $2.58-$2.60 per share, below expectations for $2.64, according to FactSet. The company also predicted to $525 million to $530 million in sales, above …
Read More »
Forex Trading Web An encyclopedia that includes everything you need to know about the forex market and the global economy.